Position in XNCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$714,888
+$376,738 QoQ
Shares Held
44,403
+58.4% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 208 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Derivatives in XNCR
reported options exposure · as of Mar 31, 2021CallValue
$0
CallShares
0
PutValue
$1,420,980
PutShares
33,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. XNCR ranks #139 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in XNCR
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $714,888 | 44,403 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $338,150 | 28,039 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $471,593 | 30,803 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $310,317 | 26,455 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $732,001 | 93,130 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,059,509 | 99,578 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $939,950 | 40,903 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $332,016 | 16,510 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $543,253 | 28,698 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $858,267 | 38,783 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $631,167 | 29,730 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $344,000 | 17,072 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $779,738 | 31,227 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,667,626 | 59,793 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $759,404 | 29,163 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,248,910 | 48,072 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $732,125 | 27,441 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,101,164 | 52,372 | Shares | Defined | 2022-04-05 | |
| 2021-09-30 | $1,002,629 | 30,699 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $755,365 | 21,901 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,710,687 | 39,728 | Shares | Defined | 2021-05-17 | |
| 2021-03-31 | $1,420,980 | 33,000 | Put | Defined | 2021-05-17 | |
| 2020-12-31 | $1,250,784 | 28,668 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $1,640,488 | 37,600 | Put | Defined | 2021-02-16 | |
| 2020-09-30 | $579,445 | 14,938 | Shares | Defined | 2020-11-16 | |
| 2020-09-30 | $217,224 | 5,600 | Call | Defined | 2020-11-16 | |
| 2020-06-30 | $327,139 | 10,100 | Put | Defined | 2020-08-14 | |
| 2020-06-30 | $422,981 | 13,059 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $645,408 | 21,600 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $692,618 | 23,180 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||